And the part about trials taking only a few weeks is a true statement. Obviously the preparation and subsequent data analysis will add some time, but the actual human trial portion of the FluCide clinical trials will take only a few weeks.
You find people with the flu, and you administer the drug or a placebo using double blind methodology. The flu runs it course in a matter of a few weeks maximum in both groups. Hopefully the treatment group will recover faster, reaching statistical significance.
That's the beauty of a TREATMENT for viral disease, as opposed to a VACCINE for viral disease (which this is not). Vaccine clinical trials take years, because you have to administer the vaccine and then wait to see who gets sick. Here, they'll select people who are already sick, and test whether and by how much the treatment speeds recovery.
best to all
Market Data 
Markets 
AI
